NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 68 filers reported holding NATERA INC in Q1 2016. The put-call ratio across all filers is 18.79 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,076 | -93.3% | 6,126 | -92.6% | 0.00% | -100.0% |
| Q2 2023 | $4,047,004 | +1264.8% | 83,169 | +1457.2% | 0.00% | – |
| Q1 2023 | $296,532 | -94.0% | 5,341 | -95.7% | 0.00% | -100.0% |
| Q4 2022 | $4,979,915 | +5142.0% | 123,971 | +5594.6% | 0.00% | – |
| Q3 2022 | $95,000 | -92.7% | 2,177 | -94.0% | 0.00% | -100.0% |
| Q2 2022 | $1,295,000 | -90.5% | 36,543 | -89.1% | 0.00% | -83.3% |
| Q1 2022 | $13,682,000 | +186.7% | 336,340 | +558.1% | 0.01% | +200.0% |
| Q4 2021 | $4,773,000 | -91.8% | 51,107 | -90.2% | 0.00% | -92.9% |
| Q3 2021 | $58,394,000 | +57.9% | 524,002 | +60.9% | 0.03% | +55.6% |
| Q2 2021 | $36,972,000 | +89.2% | 325,656 | +69.2% | 0.02% | +63.6% |
| Q1 2021 | $19,546,000 | +6.7% | 192,504 | +4.6% | 0.01% | 0.0% |
| Q4 2020 | $18,322,000 | +78.9% | 184,101 | +29.8% | 0.01% | +57.1% |
| Q3 2020 | $10,244,000 | +111.9% | 141,786 | +46.2% | 0.01% | +75.0% |
| Q2 2020 | $4,835,000 | -41.3% | 96,955 | -64.9% | 0.00% | -42.9% |
| Q1 2020 | $8,236,000 | -11.5% | 275,857 | -0.2% | 0.01% | +16.7% |
| Q4 2019 | $9,308,000 | -19.8% | 276,329 | -22.0% | 0.01% | -25.0% |
| Q3 2019 | $11,613,000 | +69.2% | 354,122 | +42.2% | 0.01% | +100.0% |
| Q2 2019 | $6,864,000 | +69.6% | 248,950 | +26.8% | 0.00% | +100.0% |
| Q1 2019 | $4,046,000 | +286.8% | 196,324 | +161.9% | 0.00% | +100.0% |
| Q4 2018 | $1,046,000 | -95.9% | 74,975 | -92.9% | 0.00% | -85.7% |
| Q3 2018 | $25,394,000 | +168.9% | 1,060,801 | +111.4% | 0.01% | +133.3% |
| Q2 2018 | $9,445,000 | +889.0% | 501,894 | +386.8% | 0.00% | – |
| Q1 2018 | $955,000 | +29.9% | 103,105 | +25.9% | 0.00% | – |
| Q4 2017 | $735,000 | +22.3% | 81,890 | +75.0% | 0.00% | – |
| Q3 2017 | $601,000 | -1.2% | 46,782 | -16.7% | 0.00% | – |
| Q2 2017 | $608,000 | +865.1% | 56,188 | +678.4% | 0.00% | – |
| Q1 2017 | $63,000 | -65.0% | 7,218 | -53.3% | 0.00% | – |
| Q4 2016 | $180,000 | 0.0% | 15,468 | -5.1% | 0.00% | – |
| Q3 2016 | $180,000 | -1.6% | 16,304 | +6.5% | 0.00% | – |
| Q2 2016 | $183,000 | +1307.7% | 15,309 | +939.3% | 0.00% | – |
| Q1 2016 | $13,000 | -50.0% | 1,473 | -41.0% | 0.00% | – |
| Q4 2015 | $26,000 | -33.3% | 2,498 | -33.5% | 0.00% | – |
| Q3 2015 | $39,000 | – | 3,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |